Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab and Radiation in HER2-negative Metastatic Breast Cancer
NCT03430479Phase 2Completed
- Sponsor
- Kyoto Breast Cancer Research Network
- Start
- Jun 2017
- Primary completion
- Nov 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in breast cancer, sponsored by Kyoto Breast Cancer Research Network. Started Jun 2017; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03430479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430479.